<DOC>
	<DOCNO>NCT01053676</DOCNO>
	<brief_summary>The study conduct randomize , non-blinded , 2-way crossover study . Target population 60 Japanese healthy male adult subject select screen examination conduct within 4 week first drug administration period 1 ( hospitalization period 1 ) . Subjects admit clinical institute Day -3 discharge Day 6 period . During hospitalization , standardized phosphate diet Day -2 Day 4 start approximately 20 minute dose . Subject take 1300 mg phosphate evenly breakfast lunch dinner day . Subject consume least 95 % meal . Distilled water include phosphate use drinking water meal . Subjects drink least 1 L distil water every day clinic make sure enough urine volume . The 24 hour urine collection conduct Day -2 Day 4 investigate urinary phosphate excretion.BAY77-1931 granule 500 mg Fosrenol chewable tablet 500 mg administer three time daily meal Day 1 Day 4 . On day 4 single dose breakfast administer . Study drug administer immediately meal , within 20 minute start meal 240 mL distilled water . A Fosrenol chewable tablet 500 mg take chew completely .</brief_summary>
	<brief_title>Bioequivalence Study BAY77-1931 Granule</brief_title>
	<detailed_description />
	<mesh_term>Hyperphosphatemia</mesh_term>
	<criteria>Japanese male volunteer must give write informed consent participate study Age 20 45 year Body Mass Index ( BMI ) 17.6 26.4 kg/m2 . Volunteers judge investigator suitable enrollment clinical trial base upon data screen test . A history relevant diseases internal organ ( disease may significantly jeopardize body system , severe liver renal dysfunction , active peptic ulcer , ulcerative colitis , Crohn 's disease , narrow colon lumen ) , central nervous system ( e.g. , epilepsy ) , organs likely show inappropriateness participation study Conditions would impair subject 's ability participate complete study opinion investigator ( mental disease think ineligible communal life study participation , unable consent participation , disables ) Known drug hypersensitivity idiosyncrasy</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>Hyperphosphatemia</keyword>
	<keyword>BE</keyword>
	<keyword>Granule</keyword>
	<keyword>Healthy volunteer</keyword>
</DOC>